Skip to main content

Table 1 Clinicopathological features of the studied NSCLC group

From: Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients

Analyzed variables

NSCLC patients

Gender (n, %)

Women (24, 41 %)

Men (35, 59 %)

Age (n, %)

Mean 61 ± 7.62

≤60 yrs (14, 24 %)

61-70 yrs (30, 51 %)

>70 yrs (15, 25 %)

Smoking status and smoking history (n, %)

Smokers (54, 92 %)

<40 Pack Yearsa (PYs) (26, 48 %)

current smokers (31, 57 %)

former smokers (23, 43 %)

≥40 PYs (28, 52 %)

non-smokers (5, 8 %)

Histopathological type of NSCLC (n, %)

SCC (34, 58 %)

NSCC (25, 42 %)

AC (20, 80 %)

LCC (5, 20 %)

AJCC classificationb (n, %)

I (11, 18 %)

II (21, 36 %)

III (27, 46 %)

Tumor size according to pTNM classificationc (n, %)

T1 (12, 20 %)

T2 (33, 56 %)

T3/T4 (14, 24 %)

  1. aPYs were calculated according to the NCI Dictionary of Cancer Terms: 1 Pack Year is equal to 20 cigarettes smoked per day for 1 year (http://www.cancer.gov/dictionary?CdrID=306)
  2. bAJCC – American Joint Committee on Cancer Staging according to the IASCLC Staging Project 7th ed. (2010) Cancer
  3. cpTNM – post-operative Tumor Node Metastasis classification according to the WHO Histological Typing of Lung Tumor